HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Bethanechol Chloride

HCID 11548
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
590-63-6
Standard SMILES
CC(C[N+](C)(C)C)OC(N)=O.[Cl-]
InChIKey
XXRMYXBSBOVVBH-UHFFFAOYSA-N
Molecular formula
C7H17ClN2O2
Average molar mass
196.67 g/mol
Monoisotopic mass
196.0978555

Overview

Bethanechol chloride is the chloride salt of bethanechol. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention. It has a role as a muscarinic agonist. It is a carbamate ester, a chloride salt and a quaternary ammonium salt. It contains a bethanechol.

Names & identifiers

Preferred name
Bethanechol Chloride
IUPAC
2-carbamoyloxypropyl(trimethyl)azanium chloride
English name
Bethanechol
Molecular formula
C7H17ClN2O2
Molecular weight
196.68

Names & synonyms

Bethanechol chloride590-63-6Myotonachol2-(carbamoyloxy)-N,N,N-trimethylpropan-1-aminium chlorideDTXSID2022676Trimethyl(2-carbamoyloxypropyl)ammonium chloride(2-Hydroxypropyl)trimethylammonium chloride carbamateH4QBZ2LO84NSC-307832-((Aminocarbonyl)oxy)-N,N,N-trimethyl-1-propanaminium chlorideCHEBI:3085DTXCID902676
Show more names
BetanecholBthanechol chlorideMictoneUro-CarbMechotaneMecothaneNSC 30783-β-methyL
NSC30783Chloride, BethanecholRefChem:54535(2RS)-2-Carbamoyloxy-N,N,N-trimethylpropylaminium chlorideUrecholineDuvoidMechothaneMictrol

Database identifiers

CAS
590-63-6
PubChem CID
11548

Properties

Computed structural properties

Topological polar surface area
52.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
4
Heavy atoms
12
Formal charge
0
Complexity
140

Experimental & physicochemical properties

Solubility>29.5 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section133 Ų [M]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
187 · 187-190°C
storage temp.
2 · Inert atmosphere,2-8°C
solubility
2 O: · H2O: 1.7 g/mL stable for several days at 4°C.
form
crystalline
color
white
Water Solubility
2 O: · H2O: 1.7g/mL (stable for several days at 4°C.)ethanol: 80mg/mL (stable for several days at 4°C.)
Merck
14 · 14,1185
InChI
InChI=1S/C7H16N2O2.ClH/c1-6(11-7(8)10)5-9(2,3)4;/h6H,5H2,1-4H3,(H-,8,10);1H
InChIKey
XXRMYXBSBOVVBH-UHFFFAOYSA-N

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 43 reports by companies from 3 notifications to the ECHA C&L Inventory.

Hazard information

Other Safety InformationIMAP assessments - 1-Propanaminium, 2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-, chloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxicology

Treatment · 1 item

Atropine Sulfate is a specific antidote. The recommended dose for adults is 0.6 mg. Repeat doses can be given every two hours, according to clinical response. The recommended dosage in infants and children up to 12 years of age is 0.01 mg/kg (to a maximum single dose of 0.4 mg) repeated every two hours as needed until the desired effect is obtained or adverse effects of atropine preclude further usage. Subcutaneous injection of atropine is preferred except in emergencies when the intravenous route may be employed. (L1712)

Exposure RoutesOral
Toxicity Summary · 1 item

Bethanechol directly stimulates cholinergic receptors in the parasympathetic nervous system while stimulating the ganglia to a lesser extent. Its effects are predominantly muscarinic, inducing little effect on nicotinic receptors and negligible effects on the cardiovascular system.

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

BETHANECHOL CHLORIDE

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Muscarinic Agonist [EPC]

MeSH Pharmacological Classification · 2 items

Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.

Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.

Uses & manufacturing

UsesFor the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
General Manufacturing Information1-Propanaminium, 2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-, chloride (1:1): ACTIVE
Applications · 5 items

DescriptionBethanechol is an agonist of muscarinic acetylcholine receptors with IC50 values of 1,837, 25, 631, 317, and 393 μM for M1-5, respectively, in a radioligand binding assay using CHO cells expressing the human receptors. It inhibits M2-mediated increases in cyclic AMP induced by isoproterenol in isolated guinea pig small intestine (IC50 = 127 μM). Bethanechol increases basal tone of isolated porcine intravesical ureter (EC50 = 4.27 μM). It also induces fluid secretion in the ileum, duodenum, and jejunum of anesthetized rats when administered at a dose of 60 μg/kg. Formulations containing bethanechol have been used to increase urination and improve smooth muscle tone in the gastrointestinal tract.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
DTXSID
DTXSID2022676
ChEMBL
CHEMBL1768
ChEBI
CHEBI:3085
UNII
H4QBZ2LO84
EC Number
209-686-8
SMILES
C(C(C)OC(=O)N)[N+](C)(C)C.[Cl-]
CAS DataBase Reference
590 · 590-63-6(CAS DataBase Reference)
FDA UNII
4 QBZ2LO84 · H4QBZ2LO84
NCI Drug Dictionary
bethanechol chloride
ATC code
7 AB02 · N07AB02
EPA Substance Registry System
1 · 1-Propanaminium, 2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-, chloride (590-63-6)
UNSPSC Code
41116107 · 41116107
NACRES
25 · NA.25
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
264 · P264-P270-P301+P312-P501
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn
Risk Statements
22 · 22
Safety Statements
36 · 36
WGK Germany
3 · 3
RTECS
5425000 · BR5425000
TSCA
TSCA listed
HS Code
2924190002 · 2924190002
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
Carcinogen Classification
No indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Bethanechol chloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
tsca
TSCA listed
rtecs
BR5425000
hs_code
2924190002
risk_code
22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
36
Storage Class
11 - Combustible Solids
Hazard statements
H302
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P264-P270-P301+P312-P501

UsesTherapeutic action of Betanechol is based on this action, and it is used for treating postoperational non-obstructive retention of urine and neurogenic bladder atony. Earlier, it was used for treating gastrointestinal illnesses and Alzheimer’s disease.

Usescholinergic

UsesA selective muscarinic receptor stimulant, used to treat cerebral palsy.

General DescriptionBethanechol, β-methylcholinechloride carbamate, (2-hydroxypropyl)trimethylammoniumchloride carbamate, carbamylmethylcholinechloride (Urecholine), is nonspecific in its action on muscarinicreceptor subtypes but appears to be more effective ateliciting pharmacological action of M3 receptors. It haspharmacological properties similar to those of methacholine.Both are esters of β-methylcholine and have feeblenicotinic activity. Bethanechol is inactivated more slowlyby AChE in vivo than is methacholine. It is a carbamyl esterand is expected to have stability in aqueous solutions similarto that of carbachol.

Upstream & downstream products

Upstream raw materials

AmmoniaPhosgene
Additional notes · 1 item

DefinitionChEBI: The chloride salt of bethanechol. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.